Jipmer becomes the first Indian center to enroll an infant in the NeoSep1 trial, targeting neonatal sepsis and antimicrobial resistance.

India is participating in the NeoSep1 clinical trial, which aims to improve treatment for drug-resistant newborn sepsis using ...

The NeoSep1 trial is expected to enroll 3,000 newborns across Asia and Africa by the end of 2028. ​Along with India, newborns ...

"Clariyon’s AI tool boosts sepsis care compliance in hospital study" was originally created and published by Clinical Trials ...

India has enrolled its first newborn in the global NeoSep1 trial at JIPMER, Puducherry. The study will test antibiotic ...

A flu outbreak at Joint Base San Antonio Lackland Air Force Base has risen to 275 confirmed cases, up from 222 earlier in the ...

The Global Antibiotic Research and Development Partnership (GARDP) said yesterday that an international clinical trial ...

In the neonatal intensive care unit, the most fragile patients in medicine are often the most heavily wired. Premature babies, some weighing less than a pound, can be tethered to a tangle of cables, ...

UnityPoint Health drove its maternal sepsis mortality rate from 3.2% to 0% by building pregnancy-specific criteria into its Epic EHR, treating 133 patients.

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every ...

Sepsis, the body’s extreme and potentially life-threatening response to an infection, has drawn renewed public attention following the death of NASCAR driver Kyle Busch at age 41. While sepsis can ...

CLEVELAND (WJW) – A legend on the track, known for speed, grit and dominance, is gone far too soon. Fans are continuing to mourn the passing of NASCAR champion Kyle Busch, a driver who defined a ...